Comparison of Once Daily 40 mg Torsemide With Twice-daily 40 mg Furosemide
NCT03509545
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
20
Enrollment
INDUSTRY
Sponsor class
Stopped
recruitment issues
Conditions
Body Weight Changes
Interventions
DRUG:
CHF Patients: ER Torsemide 40 mg
DRUG:
CHF Patients: Furosemide 40 mg
Sponsor
Sarfez Pharmaceuticals, Inc.